Best GLP-1 Providers for Type 2 Diabetes in 2026: Ranked and Reviewed
Ozempic, Ozempic tablets and Rybelsus, Mounjaro, Trulicity and Victoza are the GLP-1 brands approved to treat type 2 diabetes. Wegovy and Zepbound, the weight-management brands, are not labeled for blood sugar, and compounded semaglutide or tirzepatide carries no indication at all. None of these drugs is approved for prediabetes. Every seller below lists a price for one of the diabetes brands, and the price shown is that one. Diabetes care means glucose monitoring and a plan for your other medicines, so ask how the seller handles both.
Lowest verified price: $244/mo48 providers compared
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
48 GLP-1 providers for type 2 diabetes compared · independently scored against our six-factor methodology.
Quick Picks
What the diabetes labels cover
3 uses
on the Ozempic injection label
Ozempic's label lists glucose control in type 2 diabetes, lower odds of a heart attack, a stroke or a cardiovascular death when heart disease is also present, and slower loss of kidney function when chronic kidney disease is.[12]
Ozempic label and prices →Age 10 and up
Mounjaro's glucose indication
Mounjaro is labeled for glucose control in type 2 diabetes from age 10 upward, and, for adults with the disease whose heart risk is high, for fewer major cardiovascular events.[13]
Mounjaro label and prices →-2.30 vs -1.86
points of HbA1c, SURPASS-2
In SURPASS-2, tirzepatide 15 mg lowered HbA1c by 2.30 percentage points against 1.86 for semaglutide 1 mg over 40 weeks, and all three tirzepatide doses beat semaglutide on weight as well.[14]
Ozempic vs Mounjaro →One a day
Ozempic tablets and Rybelsus
Oral semaglutide is labeled for glucose control in type 2 diabetes and, where heart risk is high, for fewer major cardiovascular events. Weight loss is not on its label; the Wegovy pill's label covers that.[15]
Ozempic tablets explained →
Compare the top providers at a glance
Every row carries a logo, our editorial rating, price, the medications prescribed, and where the seller ships. Scan down a column and the list shortens fast.
- ★ Editor's Pick
type 2 diabetes care, with Ozempic on its price list
From /mo$1,299Flat at every doseCoverage50 statesMedicationsSemaglutide - Best Budget
type 2 diabetes care, with Ozempic on its price list
From /mo$705Scales with doseCoverage50 statesMedicationsSemaglutide - Nationwide Coverage
type 2 diabetes care, with Ozempic and Mounjaro on its price list
From /mo$1,149Flat at every doseCoverage50 statesMedicationsSemaglutideTirzepatide
Show 5 moreShow fewer
type 2 diabetes care, with Ozempic on its price list
From /mo$1,200Flat at every doseCoverage50 statesMedicationsSemaglutidetype 2 diabetes care, with Ozempic on its price list
From /mo$1,299Flat at every doseCoverage50 statesMedicationsSemaglutidetype 2 diabetes care, with Mounjaro on its price list
From /mo$1,399Coverage50 states + DCMedicationsTirzepatidetype 2 diabetes care, with Ozempic and Mounjaro on its price list
From /mo$1,299Flat at every doseCoverage50 states + DCMedicationsSemaglutideTirzepatidetype 2 diabetes care, with Ozempic and Mounjaro on its price list
From /mo$1,300Flat at every doseCoverage50 statesMedicationsSemaglutideTirzepatide
| Provider | Rating | From /mo | Medications | Coverage | |
|---|---|---|---|---|---|
★ Editor's Pick type 2 diabetes care, with Ozempic on its price list | $1,299 Flat pricing | Semaglutide | 50 states | Visit → | |
Best Budget type 2 diabetes care, with Ozempic on its price list | $705 Scales by dose | Semaglutide | 50 states | Visit → | |
Nationwide Coverage type 2 diabetes care, with Ozempic and Mounjaro on its price list | $1,149 Flat pricing | SemaglutideTirzepatide | 50 states | Visit → | |
 type 2 diabetes care, with Ozempic on its price list | $1,200 Flat pricing | Semaglutide | 50 states | Visit → | |
 type 2 diabetes care, with Ozempic on its price list | $1,299 Flat pricing | Semaglutide | 50 states | Visit → | |
 type 2 diabetes care, with Mounjaro on its price list | $1,399 | Tirzepatide | 50 states + DC | Visit → | |
 type 2 diabetes care, with Ozempic and Mounjaro on its price list | $1,299 Flat pricing | SemaglutideTirzepatide | 50 states + DC | Visit → | |
 type 2 diabetes care, with Ozempic and Mounjaro on its price list | $1,300 Flat pricing | SemaglutideTirzepatide | 50 states | Visit → |
All 48 providers on this board, in the order this board shows them
The comparison above shows the first 8. This is the full list the filter counts refer to, in the order this board shows them; each name opens that provider’s review.
- Tryozi
- Care Bare Rx
- altRX
- Astra
- Gala
- Vytora Health
- Pallas Health
- Effecty
- Sesame Care
- NuuVim
- GOAL.MD
- NovoCare Pharmacy
- RxSpan MD
- Luvo Health
- Wellya
- Vital Edge
- XMD Wellness
- Peptivo
- Knownwell
- NoBsRx
- Synergy Rx
- Wellorithm
- MEDGm
- Maximus
- Oak
- Mochi Health
- Corsica Health
- KairoRx
- DudeMeds
- Good Girl Rx
- Layla
- Eve
- Trimrose
- Nucific
- AlyveRx
- TrimRx
- SkinnyRx
- WellMedRx
- Josie
- Aquivia Health
- Concierge MD LA
- Fridays
- Noom
- Elevated Health
- myRocky
- Remmy
- WeightWatchers
- VivioMD
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
Detailed Reviews
Tryozi
Best for: type 2 diabetes care, with Ozempic on its price list
Tryozi Group LLC, of Pembroke Pines, Florida, sells compounded semaglutide at $79 a month and tirzepatide at $129, billed monthly and sold as a lifetime deal against struck-through prices of $279 and $379. One price applies at every dose, and it covers the consult, base labs and shipping. It names its four 503A pharmacies, and also lists brand Ozempic at $1,299 and Zepbound at $1,399.
Score Breakdown
Pros
- ✓Semaglutide costs $79 a month, 60% below the $199 median for compounded semaglutide across the sellers we compare
- ✓Tirzepatide costs $129 a month, 52% below the $269 median for compounded tirzepatide across the sellers we compare
- ✓Shows its price before the medical questionnaire, so you can compare it without handing over health information
- ✓The monthly price stays the same as your dose goes up
- ✓The monthly price includes the medication, clinician visits, shipping and lab work
- ✓Serves all 50 states
- ✓Names 4 pharmacies that fill its prescriptions, which most sellers do not
- ✓We found no FDA warning letters issued to Tryozi
Cons
- ✗Its compounded semaglutide and tirzepatide are not FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Care Bare Rx
Best for: type 2 diabetes care, with Ozempic on its price list
Prices at Care Bare Rx begin at $199/month for compounded semaglutide and tirzepatide, with brand-name Ozempic available as well. The footprint is all 50 states plus Puerto Rico. It bills itself as LGBTQ+-inclusive, and it shares a clinician and 4-pharmacy network run by Lion MD with Synergy Rx and Breeze Meds.
Score Breakdown
Pros
- ✓Semaglutide costs $705 a month, 46% below the $1,299 median for brand-name semaglutide across the sellers we compare
- ✓Shows its price before the medical questionnaire, so you can compare it without handing over health information
- ✓The monthly price includes the medication, clinician visits and shipping
- ✓Serves all 50 states
- ✓Names 4 pharmacies that fill its prescriptions, which most sellers do not
- ✓We found no FDA warning letters issued to Care Bare Rx
Cons
- ✗Its compounded semaglutide and tirzepatide are not FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
altRX
Verified partnerBest for: type 2 diabetes care, with Ozempic and Mounjaro on its price list
Score breakdown, pros and cons
Compounded plans open at $89 for semaglutide and $149 for tirzepatide, the same at every dose. Branded medication runs $1,149-$1,579, a figure that already contains the consult and the shipping. Every one of the four FDA-approved brands is stocked, Mounjaro, Ozempic, Wegovy and Zepbound, which no other entry in our directory matches. altRX works in both modalities, holds LegitScript certification, and prints the FDA compounded-medication disclaimer. FDA sent its operator a warning letter in June 2026.
Score Breakdown
Pros
- ✓Semaglutide costs $89 a month, 55% below the $199 median for compounded semaglutide across the sellers we compare
- ✓Tirzepatide costs $149 a month, 45% below the $269 median for compounded tirzepatide across the sellers we compare
- ✓Shows its price before the medical questionnaire, so you can compare it without handing over health information
- ✓The monthly price stays the same as your dose goes up
- ✓The monthly price includes the medication, clinician visits and shipping
- ✓Serves all 50 states
- ✓Names 4 pharmacies that fill its prescriptions, which most sellers do not
Cons
- ✗The FDA has issued altRX a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
- ✗Its compounded semaglutide and tirzepatide are not FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Astra
Best for: type 2 diabetes care, with Ozempic on its price list
Score breakdown, pros and cons
Astra is an online clinic that prescribes compounded semaglutide and tirzepatide, brand-name Wegovy, Ozempic and Zepbound, and sermorelin, NAD+ and glutathione, through a named Florida medical group and named 503A pharmacies. Plans are paid up front and renew automatically: semaglutide is $145 a month or $68 a month on a 12-month plan billed $816 at once, and tirzepatide is $250 a month or $118 a month on the 12-month plan, at any dose.
Score Breakdown
Pros
- ✓Semaglutide costs $145 a month, 27% below the $199 median for compounded semaglutide across the sellers we compare
- ✓Tirzepatide costs $250 a month, close to the $269 median for compounded tirzepatide across the sellers we compare
- ✓Shows its price before the medical questionnaire, so you can compare it without handing over health information
- ✓The monthly price stays the same as your dose goes up
- ✓The monthly price includes the medication, clinician visits and shipping
- ✓Serves all 50 states
- ✓Names 6 pharmacies that fill its prescriptions, which most sellers do not
- ✓We found no FDA warning letters issued to Astra
Cons
- ✗Its compounded semaglutide and tirzepatide are not FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Gala
Verified partnerBest for: type 2 diabetes care, with Ozempic on its price list
Score breakdown, pros and cons
A yearly plan is the format: compounded semaglutide and compounded tirzepatide are sold that way, with brand-name Ozempic on the same menu. The corporate name is AI Coaching Inc., which does business as Gala GLP-1 and is incorporated in Delaware; care comes through OpenLoop-affiliated medical groups. Compounded GLP-1 is $179 a month on the yearly plan, all doses included. A Wegovy pill taken orally is flagged as coming soon.
Score Breakdown
Pros
- ✓Semaglutide costs $179 a month, 10% below the $199 median for compounded semaglutide across the sellers we compare
- ✓Tirzepatide costs $179 a month, 33% below the $269 median for compounded tirzepatide across the sellers we compare
- ✓Shows its price before the medical questionnaire, so you can compare it without handing over health information
- ✓The monthly price stays the same as your dose goes up
- ✓The monthly price includes the medication, clinician visits and shipping
- ✓Serves all 50 states
- ✓We found no FDA warning letters issued to Gala
Cons
- ✗Ask which pharmacy fills the prescription before you pay, so you can check its license
- ✗Its compounded semaglutide and tirzepatide are not FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
How we rank, and what counts as “legit”
Scoring for every provider on this page runs against our published six-factor rubric[1]: value, effectiveness, user experience, trust & safety, accessibility and support.
Each of Wegovy, Zepbound, Ozempic and Mounjaro holds its own separate FDA approval under its own NDA number[4][5]. Published Phase 3 efficacy for semaglutide at 2.4 mg (~14.9% mean weight loss across 68 weeks) comes from STEP 1[6]; those for tirzepatide (~20.9% at the 15 mg dose over 72 weeks) come from SURMOUNT-1[7]. In 2025 the SURMOUNT-5 head-to-head set the two against each other[8].
How much of an anti-obesity medication is covered varies widely between state Medicaid programs and between commercial plans[9][10]. Under IRS Publication 502, compounded GLP-1s and brand-name ones alike are generally FSA/HSA eligible where a prescription exists[11].
Related research
The board lists who sells the diabetes brands. These pages cover the drugs themselves, combining them with metformin, and where prediabetes and type 1 diabetes stand.
Frequently Asked Questions
Sources & methodology — as of November 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 5.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 8.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.
- 9.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 10.CMS — Medicaid prescription drug coverage policy (state-by-state)— Centers for Medicare & Medicaid Services.
- 11.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.
- 12.Ozempic (semaglutide) injection prescribing information, DailyMed SPL— Novo Nordisk, via the National Library of Medicine (DailyMed).
- 13.Mounjaro (tirzepatide) prescribing information, DailyMed SPL— Eli Lilly and Company, via the National Library of Medicine (DailyMed).
- 14.SURPASS-2 Trial — Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes (Frías JP et al.)— New England Journal of Medicine.PMID: 34170647.
- 15.Rybelsus and Ozempic (semaglutide) tablets prescribing information, DailyMed SPL— Novo Nordisk, via the National Library of Medicine (DailyMed).